
Researchers validated a sensitive and specific liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for simultaneous quantification of 6-MP, 6-TG, and 6-MMP in red blood cells. Demonstrating excellent linearity, accuracy, and precision, the approach supports routine therapeutic drug monitoring and advances personalized thiopurine therapy.





























